Post-IPO Equity Funded Startups in Israel
The disclosed post-IPO equity rounds in this Israel list are dominated by a single outlier: Arbe’s $100M round (2021-10-08), followed by materially smaller…
The disclosed post-IPO equity rounds in this Israel list are dominated by a single outlier: Arbe’s $100M round (2021-10-08), followed by materially smaller figures such as Allot’s $40M (2022-02-15) and PulseNmore’s $50M (2022-05-12). The smallest disclosed amount is Wilk’s $1M (2021-07-12), and the gap between that floor and the $100M top end is much wider than the differences among mid-tier rounds (for example, $3M–$5M entries across 2021-10 to 2022-04).
The 18 rows shown cluster tightly in time: 10 of the 18 rounds fall between 2022-05-09 and 2022-09-22, with only one entry outside 2021-07-12 to 2022-09-22. Sector-wise, Biotechnology is the most frequent label, appearing in 6 of the 18 rows (e.g., MediWound on 2022-09-22 for $30M, RedHill Biopharma on 2022-05-09 for $15M, and SciSparc on 2022-05-27 for $10M). Undisclosed amounts recur in multiple rounds (4 of 18 are “undisclosed” such as Wix on 2022-09-06 and Otonomo on 2022-07-26).
Most recent rounds
18 shownRelated listings
Frequently asked
What does the largest disclosed post-IPO equity round look like versus the rest of the table, and what’s the disclosed low end?
Arbe’s $100M round on 2021-10-08 dwarfs the next-highest disclosed amounts visible here, including PulseNmore’s $50M (2022-05-12) and Allot’s $40M (2022-02-15). At the low end, Wilk’s disclosed amount is $1M on 2021-07-12, creating a much wider spread than the differences among the $3M–$15M cluster (for example, IR-MED $3M on 2022-04-14 versus RedHill Biopharma $15M on 2022-05-09).
Are there concentrated time windows for these post-IPO equity rounds (based on the most recent 18 entries)?
Yes. Ten of the 18 rows close between 2022-05-09 (RedHill Biopharma) and 2022-09-22 (MediWound), including a dense mid-summer stretch with multiple rounds in July–August 2022 such as Safe-T $4M (2022-08-10), Save Foods $5M (2022-08-15), and IM Cannabis $5M (2022-08-19). The oldest date in the rows is 2021-07-12 (Wilk) and the most recent is 2022-09-22 (MediWound).
Which sectors are over-represented, and how does that show up in the disclosed amounts?
Biotechnology is the dominant sector label, appearing in 6 of the 18 rows (MediWound $30M on 2022-09-22; SciSparc $10M on 2022-05-27; RedHill Biopharma $15M on 2022-05-09; plus CanFite BioPharma $10M on 2021-08-12; BIOMx $3M on 2022-01-04; Kadimastem $5M on 2021-10-26). The disclosed amounts among these biotech entries span from $3M to $30M, suggesting breadth rather than a single narrow funding band within the sector.
How often are amounts undisclosed, and are they clustered around particular dates or companies?
Undisclosed amounts appear in 4 of the 18 rows: Wix (2022-09-06), Otonomo (2022-07-26), MeaTech (2022-04-13), and explicitly another “undisclosed” entry is present among the 18 records (two July–September 2022 examples sit close to the top of the date range). Those undisclosed cases reduce the number of comparable disclosed datapoints in the 2022-04 to 2022-09 period where many of the disclosed rounds also cluster.
Which cities show repeated geographic presence in this listing, and what’s the most prominent pattern?
Tel Aviv (as a city label) appears repeatedly, including MediWound’s Tel Aviv region listing (Yavne, Israel but within the Tel Aviv/Hamerkaz axis shown), and multiple records explicitly list Tel Aviv such as Allot’s Hod Hasharon (2022-02-15) and SuperCom’s Herzliya (2022-02-25) with Tel Aviv noted in the location field. Herzliya is also a recurring city label (Safe-T on 2022-08-10, Otonomo on 2022-07-26), and several companies list Ness Ziona/Hamerkaz in adjacent timeframes (BIOMx 2022-01-04; MeaTech 2022-04-13; Kadimastem 2021-10-26).
Are there notable outliers beyond the top funding size, such as unusually small disclosed rounds or sector-specific extremes?
Yes. The smallest disclosed amount is Wilk’s $1M (2021-07-12) in Agriculture and Farming, which sits far below the general $3M–$15M cluster seen in several other sectors around 2022-01 to 2022-05 (e.g., BIOMx $3M on 2022-01-04 and IR-MED $3M on 2022-04-14). On the high end, the single largest disclosed round is tied to AI via Arbe ($100M on 2021-10-08), while other very large disclosed rounds in biotech and software—such as RedHill Biopharma $15M (biotech) and PulseNmore $50M (Apps)—do not match that scale in the visible rows.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.